Anika Therapeutics Inc. (ANIK) vs Siga Technologies Inc. (SIGA)

Anika Therapeutics Inc. and Siga Technologies Inc. are both Drug Manufacturers Specialty & Generic companies. Anika Therapeutics Inc. is the larger, with a market value of $258.7M against $213.4M — 1.2× the size. Anika Therapeutics Inc. grew revenue faster over the last twelve months: 5.33% against −70.1%. Anika Therapeutics Inc. has the higher net margin (−3.14% vs −5.19%) and the higher return on invested capital (−3.24% vs −14.6%). Across the 17 metrics below, Anika Therapeutics Inc. leads on 12 and Siga Technologies Inc. on 5.

Valuation

Metric ANIK SIGA Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 2.13 3.97 2.08
P/B 1.88 1.29 1.79
Price to free cash flow 458.01 n/m 16.29
EV/EBITDA 476.54 n/m 12.22
EV/Sales 2.02 4.74 2.87
Earnings yield (1.35%) (1.35%) (15.94%)
Free cash flow yield 0.22% (9.63%) 0.00%

Profitability

Metric ANIK SIGA Drug Manufacturers Specialty & Generic median
Gross margin 62.16% 54.35% 53.51%
Operating margin (4.24%) (20.76%) 0.00%
Net margin (3.14%) (5.19%) (2.45%)
Free cash flow margin 0.47% (37.58%) 0.00%
Return on equity (2.66%) (1.49%) (0.80%)
Return on assets (2.04%) (1.36%) (1.67%)
Return on invested capital (3.24%) (14.59%) 0.00%

Growth

Metric ANIK SIGA Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 5.33% (70.13%) 5.22%
EPS growth (last fiscal year) 80.16% (60.98%) 42.91%
Revenue growth, 5-year CAGR (2.86%) (5.42%) 7.24%
Net income growth, 5-year CAGR 0.00% (16.20%) 0.00%

Health

Metric ANIK SIGA Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.00 0.04
Current ratio 4.48 21.72 2.41
Net debt to EBITDA 10.80 (6.39) 1.01

Dividend

Metric ANIK SIGA Drug Manufacturers Specialty & Generic median
Dividend yield — 0.00% 1.45%
Payout ratio — — 0.27

Size

Metric ANIK SIGA Drug Manufacturers Specialty & Generic median
Market cap 258.69m 213.40m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack